From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Folate and Vitamin B12 Prevent Hip Fracture in Stroke Patients

Japanese researchers found a benefit similar to that seen in previous trials of alendronate and raloxifene.

Risk for hip fracture and associated osteoporosis is two to four times higher among stroke patients than among age-matched controls; it is also higher in paretic limbs than in unaffected limbs. High homocysteine levels and deficiencies in folate or vitamin B12 might play a role, given the observed association between homocysteine levels and fracture risk (Journal Watch Jun 1 2004).

Japanese investigators randomized 628 stroke patients (age, ≥65) without previous fractures to daily supplementation with folate (5 mg) plus mecobalamine (1500 µg) or double placebo. Subjects had high baseline homocysteine levels and low vitamin B12 levels, relative to reference levels in healthy older Japanese people.

By 2 years, 6 hip fractures had occurred in the treatment group, and 27 had occurred in the placebo group; relative risk reduction with treatment was 0.78, and absolute risk reduction was 6.7%, which yielded a number needed to treat (NNT) of 15 to prevent 1 fracture. In both treatment and control groups, mean BMD was significantly lower on the hemiplegic side than on the unaffected side, and BMD had not improved in either hip at 2-year follow-up.

Comment: These results are unexpectedly large in magnitude and deserve replication in both stroke and nonstroke populations. The magnitude of benefit is similar to that found in trials of alendronate and raloxifene, with considerably less potential risk. The fact that BMD did not change suggests the benefit derives from quality, rather than quantity, of bone.

— Thomas L. Schwenk, MD

Published in Journal Watch General Medicine March 25, 2005

Citation(s):

Sato Y et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: A randomized controlled trial. JAMA 2005 Mar 2; 293:1082-8.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.